Question: If I have a patient with asthma and COVID-19, what changes to the treatment plan should be made?

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Asthma
Are any changes recommended to the asthma treatment plan if my patient with asthma has COVID-19?
section_content: Patients can be referred to CDC’s recommendations for caring for themselves
or someone else at home sick with COVID-19.
If nebulizer use at home is necessary for patients with asthma who have
symptoms or a diagnosis of COVID-19, use of the nebulizer in a location that
minimizes and preferably avoids exposure to any other members of the
household, and preferably a location where air is not recirculated into the
home (like a porch, patio, or garage) is recommended by national professional
organizations, including the American College of Allergy, Asthma & Immunology
(ACAAI) by the ACAAI and the Allergy & Asthma Network (AAN). Limiting the
number of people in the room or location where the nebulizer is used is also
recommended by the Asthma & Allergy Foundation of America (AAFA). Nebulizers
should be used and cleaned according to the manufacturer’s instructions.
If nebulizer use in a healthcare setting is necessary for patients who have
either symptoms or a diagnosis of COVID-19, use CDC’s recommended precautions
when performing aerosol-generating procedures
(AGPs).

Reviewer feedback on this answer:
Detailed answer is given regarding how to treat a patient with asthma and COVID-19 as well as specifics regarding nebulizers themselves.
Gives specific advice about how to adjust treatment plans for asthma patients who catch COVID-19.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Asthma
If my patient experiences an asthma exacerbation, should the exacerbation be treated any differently to reduce risk of COVID-19?
section_content: Selection of therapeutic options through guideline-recommended treatment of
asthma exacerbations has not been affected by what we currently know about
COVID-19.
Systemic corticosteroids should be used to treat an asthma exacerbation per
national asthma guidelinesexternal icon and current standards of
care, even if it is caused by COVID-19. Short-term use of systemic
corticosteroids to treat asthma exacerbations should be continued. There is
currently no evidence to suggest that short-term use of systemic
corticosteroids to treat asthma exacerbations increases the risk of developing
severe COVID-19, whereas there is an abundance of data to support use of
systemic steroids for moderate or severe asthma exacerbations.
Patients with asthma but without symptoms or a diagnosis of COVID-19 should
continue any required nebulizer for treatments, as recommended by national
professional organizations, including the American Academy of Allergy, Asthma
& Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology
(ACAAI). If healthcare providers need to be present during nebulizer use among
patients who have either symptoms or a diagnosis of COVID-19, use CDC’s
recommended precautions when performing aerosol-generating procedures
(AGPs).
Clinicians may be concerned that an asthma exacerbation is related to an
underlying infection with COVID-19. Clinicians can access laboratory testing
for COVID-19 through a network of state and local public health laboratories
across the country. Lists of states and territories with
laboratories that are
using COVID-19 viral tests are available. For more information, see Testing
in U.S. Clinicians
should direct testing questions to their
state
and localexternal icon
health departments.

Reviewer feedback on this answer:
Gives detailed technical advice on treating COVID-19 comorbid with asthma.
Very detailed answers on what to do regarding existing treatment options for asthma when COVID-19 is also present as well as links to more information as needed if testing is needed.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: CDC):
page_title: People with Moderate to Severe Asthma
section_headers: Follow your Asthma Action Plan
section_content: 
Keep your asthma under control by following your asthma action plan.
Continue your current medications, including any inhalers with steroids in them (“steroids” is another word for corticosteroids).
Don’t stop any medications or change your asthma treatment plan without talking to your healthcare provider.
Discuss any concerns about your treatment with your healthcare provider.
Talk to your healthcare provider, insurer, and pharmacist about creating an emergency supply of prescription medications, such as asthma inhalers. Make sure that you have 30 days of non-prescription medications and supplies on hand too in case you need to stay home for a long time.
Know how to use your inhaler.
Avoid your asthma triggers.
As more cases of COVID-19 are discovered and our communities take action to combat the spread of disease, it is natural for some people to feel concerned or stressed. Strong emotions can trigger an asthma attack. Take steps to help yourself cope with stress and anxiety.

For information on administering asthma medication in schools, visit K-12
Schools and Child Care Programs.

Reviewer feedback on this answer:
Addresses how people with asthma should prepare for COVID-19, but doesn't specify how treatment plans should be modified beyond advising people to contact their doctors.
The answer is more geared toward the patient themselves rather than the provider but the provider at least has some guidance on what to do. However, it is not as detailed regarding what treatments would need to change and rather directs them to a "healthcare provider" who is asking the question to begin with.

Reviewer ratings:
Acceptable
Acceptable